Dunhill Financial’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
Dunhill Financial's EVH Position: Q3 2026 in Review
Dunhill Financial reduced its Evolent Health (EVH) stake by 40% in Q3 2026, selling an estimated $9 and leaving 3 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #1807.
Dunhill Financial first reported a position in EVH in Q4 2025 and has held it in 4 quarters since. The position peaked at $28 in Q2 2026. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.
- Dunhill Financial held 3 shares of Evolent Health worth $18 as of Q3 2026.
- Dunhill Financial sold 2 Evolent Health shares in Q3 2026, an estimated $9.
- Evolent Health made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1807 holding.
- Dunhill Financial first reported a position in Evolent Health in Q4 2025 and has held it in 4 quarters since.
- Dunhill Financial's Evolent Health position peaked at $28 in Q2 2026.
- 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.